Treatment in first line of mantle cell lymphoma for patients under 66 Years by the VAD [vincristine + doxorubicin + dexamethasone] -chlorambucil -rituximab regimen followed by intensification and autologous PBSC [Peripheral blood stem cell] transplantation after marrow purging with rituximab
Phase of Trial: Phase II
Latest Information Update: 04 Apr 2016
At a glance
- Drugs Rituximab (Primary) ; Chlorambucil; Dexamethasone; Doxorubicin; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 11 Feb 2009 Actual end date (Dec 2008) added as reported by ClinicalTrials.gov.
- 31 Jul 2006 New trial record.